Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 605-315-2 | CAS number: 163149-28-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Acute/short term exposure
DNEL related information
Local effects
Acute/short term exposure
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Acute/short term exposure
DNEL related information
Workers - Hazard for the eyes
Additional information - workers
Poly alpha olefins and their respective structural analogues were not acutely toxic when administered via oral or dermal routes in several animal studies. Hence, these substances do not meet the classification and labelling criteria for acute oral or dermal toxicants as defined by EU DSD/DPD 67/548/EEC or CLP EU Regulation 1272/2008 (GHS aligned) criteria; therefore DNELs were not derived for these endpoints.
The available acute inhalation toxicity data indicate that some poly alpha olefins (viscosity <15 cSt at 40 ° C, average carbon number <C-30) are acutely toxic in experimental animal studies with inhalation LC50 values consistent with EU labelling requirements for Xn/R20 (Directive 67/548 EEC) or Acute Tox. 4, H332 (Regulation 1272/2008); a DNEL is required for substances meeting these physico-chemical criteria or where experimental data indicate a LC50 below 5 mg/L. However test data available for other samples with kinematic viscosity >15 cSt at 40 °C and an average C-number of 30 or higher return LC50 values in excess of 5 mg/L; no classification or DNEL is required for these substances.
Based on read-across to 1-dodecene polymer with 1-decene, hydrogenated (structural analogue for Alkane 5 with reported LC50 value > 5.0 mg/L), 1-dodecene, polymer with 1-decene and 1-octene, hydrogenated does not require classification for acute inhalation toxicity as defined by EU Dangerous Substance Directive 67/548/EEC or CLP Regulation 1272/2008 (GHS aligned); therefore no DNEL is required.
Regulatory classification and labeling for aspiration toxicity relies on the measured or calculated kinematic viscosity of a substance at 40°C rather than results from toxicological studies with animals.There are no viscosity data available for 1-dodecene, polymer with 1-decene and 1-octene, hydrogenated. However, read-across viscosity data was available for 1-dodecene polymer with 1-decene, hydrogenated. The reported kinematic viscosity value for 1-dodecene polymer with 1-decene, hydrogenated is 15-20 cSt (Exxon Mobil, 2010). This value exceeds the discriminating threshold for classification for aspiration hazard (<7 cSt) under the DSD but meets the criteria for classification as a Category 1 aspiration hazard under CLP (< 20.5 cSt). Based on the read-across strategy used for poly alpha olefins, it is therefore inferred that 1-dodecene, polymer with 1-decene and 1-octene, hydrogenated is classified as a Category 1 aspiration hazard, H304: (May be fatal if swallowed and enters airway) in accordance with CLP Regulation 1272/2008 (GHS aligned). A DNEL is neither feasible nor appropriate for this endpoint
A one-generation reproductive toxicity study in which Alkane 4 (a structural analogue to 1-decene trimer, hydrogenated and tetramers) was administered via oral gavage to rats showed no adverse effects on fertility or development at the highest dose tested of 1000 mg/kg bw/day (Knox et al., 2007). Additionally, rats exposed to Ethylflo 166 (1-decene homopolymer hydrogenated) in utero were again treated with Ethyflo 166 for an additional 91 days beginning 22 days after birth (Daniel, 1994). There were no treatment-related effects reported at the highest dose tested (1000 mg/kg bw/day) in the parental generation, offspring at birth, or following 91 days of subsequent oral exposure. The weight of evidence presented by these studies suggests that poly alpha olefins, as a group, are unlikely to present a significant hazard potential to fertility and development; therefore no DNEL for reproductive toxicity is necessary.
Workers
A worker-DNELlong-term for dermal route-systemic and worker-DNELlong term for inhalation route-systemic were not derived for poly alpha olefins because no adverse findings relevant to human health risk assessment were found in several, good quality, high reliability repeated dose studies with these substances at doses at or exceeding a limit dose of 1000 mg/kg bw/day (Daniel, 1994, Cooper, 1995, and Knox et al., 2007). These results indicate that poly alpha olefins, as a class, possess an inherently low hazard potential with regard to human health. Therefore, derivation of DNELs is unnecessary. A worker-DNELlong-term for oral route-systemic was not calculated for poly alpha olefins because oral exposure to these substances was not considered a relevant route of exposure for a worker population based on ‘normal’ use of these substances in a workplace setting.
General Population - Hazard via inhalation route
Systemic effects
Acute/short term exposure
DNEL related information
Local effects
Acute/short term exposure
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Acute/short term exposure
DNEL related information
General Population - Hazard via oral route
Systemic effects
Acute/short term exposure
DNEL related information
General Population - Hazard for the eyes
Additional information - General Population
General Population
General population DNELs for acute effects were not derived because no relevant hazard was apparent from the available toxicological data.
A general population-DNELlong-term for oral route-systemic, general population-DNELlong-term for dermal route-systemic, and general population-DNELlong term for inhalation route-systemicwere not derived for poly alpha olefins because no adverse findings relevant to human health risk assessment were found in several, good quality, high reliability repeat dose studies with these substances at doses at or exceeding a limit dose of 1000 mg/kg bw/day (Daniel, 1994, Cooper, 1995, and Knox et al., 2007). These results indicate that poly alpha olefins, as a class, possess an inherently low hazard potential with regard to human health. Therefore, derivation of DNELs is unnecessary.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.